Display options
Cite
Szema AM, Dang S, Li JC. Emerging Novel Therapies for Heart Failure. Clin Med Insights Cardiol. 2015;9:57-64doi: 10.4137/CMC.S29735.
Szema, A. M., Dang, S., & Li, J. C. (2015). Emerging Novel Therapies for Heart Failure. Clinical Medicine Insights. Cardiology, 957-64. https://doi.org/10.4137/CMC.S29735
Szema, Anthony M, et al. "Emerging Novel Therapies for Heart Failure." Clinical Medicine Insights. Cardiology vol. 9 (2015): 57-64. doi: https://doi.org/10.4137/CMC.S29735
Szema AM, Dang S, Li JC. Emerging Novel Therapies for Heart Failure. Clin Med Insights Cardiol. 2015 Oct 11;9:57-64. doi: 10.4137/CMC.S29735. eCollection 2015. PMID: 26512208; PMCID: PMC4603524.
Copy Download .nbib Format: NLM
Share it on

Clin Med Insights Cardiol. 2015 Oct 11;9:57-64. doi: 10.4137/CMC.S29735. eCollection 2015.

Emerging Novel Therapies for Heart Failure.

Clinical Medicine Insights. Cardiology

Anthony M Szema, Sophia Dang, Jonathan C Li

Affiliations

  1. Department of Technology and Society, College of Engineering and Applied Sciences, Stony Brook University, Stony Brook, NY, USA. ; Department of Occupational Medicine, Preventive Medicine, and Epidemiology, Hofstra North Shore-LIJ School of Medicine, Hofstra University, Hempstead, NY, USA. ; The Stony Brook Medicine SUNY, Stony Brook Internal Medicine Residency Program, John T. Mather Memorial Hospital, Port Jefferson, NY, USA. ; Three Village Allergy and Asthma, PLLC South Setauket, NY, USA.
  2. Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA, USA.
  3. Three Village Allergy and Asthma, PLLC South Setauket, NY, USA. ; Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA, USA.

PMID: 26512208 PMCID: PMC4603524 DOI: 10.4137/CMC.S29735

Abstract

Heart function fails when the organ is unable to pump blood at a rate proportional to the body's need for oxygen or when this function leads to elevated cardiac chamber filling pressures (cardiogenic pulmonary edema). Despite our sophisticated knowledge of heart failure, even so-called ejection fraction-preserved heart failure has high rates of mortality and morbidity. So, novel therapies are sorely needed. This review discusses current standard therapies for heart failure and launches an exploration into emerging novel treatments on the heels of recently-approved sacubitril and ivbradine. For example, Vasoactive Intestinal Peptide (VIP) is protective of the heart, so in the absence of VIP, VIP knockout mice have dysregulation in key heart failure genes: 1) Force Generation and Propagation; 2) Energy Production and Regulation; 3) Ca(+2) Cycling; 4) Transcriptional Regulators. VIP administration leads to coronary dilation in human subjects. In heart failure patients, VIP levels are elevated as a plausible endogenous protective effect. With the development of elastin polymers to stabilize VIP and prevent its degradation, VIP may therefore have a chance to satisfy the unmet need as a potential treatment for acute heart failure.

Keywords: VIP; genes; heart failure; ivbradine; knockout mice; novel therapies; sacubitri; vasoactive intestinal peptide

References

  1. Curr Opin Allergy Clin Immunol. 2013 Aug;13(4):337-44 - PubMed
  2. Trends Neurosci. 1993 Jun;16(6):233-40 - PubMed
  3. Eur J Heart Fail. 2014 Jun;16(6):671-7 - PubMed
  4. Prog Biophys Mol Biol. 2004 Jun-Jul;85(2-3):261-78 - PubMed
  5. J Clin Pharmacol. 2010 Apr;50(4):401-14 - PubMed
  6. Circulation. 2013 Oct 15;128(16):1810-52 - PubMed
  7. J Mol Cell Cardiol. 2010 Feb;48(2):286-92 - PubMed
  8. Am Fam Physician. 2006 Mar 1;73(5):841-6 - PubMed
  9. J Biol Chem. 2015 Sep 4;290(36):22085-100 - PubMed
  10. Am J Physiol Cell Physiol. 2008 Feb;294(2):C477-87 - PubMed
  11. Circ Res. 2014 Jan 17;114(2):295-306 - PubMed
  12. Front Physiol. 2011 Oct 19;2:67 - PubMed
  13. Biochem Soc Trans. 2014 Feb;42(1):89-97 - PubMed
  14. FEBS J. 2013 May;280(10 ):2382-98 - PubMed
  15. JAMA. 1995 May 10;273(18):1450-6 - PubMed
  16. Ital Heart J Suppl. 2000 May;1(5):679-85 - PubMed
  17. J Cardiovasc Dis. 2014 Apr 1;2(3):131-136 - PubMed
  18. Can J Physiol Pharmacol. 2012 Aug;90(8):1017-28 - PubMed
  19. Am J Physiol. 1986 Jul;251(1 Pt 1):C115-9 - PubMed
  20. Am J Physiol. 1995 Jun;268(6 Pt 1):L1047-51 - PubMed
  21. J Card Fail. 1999 Jun;5(2):127-38 - PubMed
  22. N Engl J Med. 2014 Sep 11;371(11):1062-4 - PubMed
  23. J Cardiovasc Pharmacol. 1990 Dec;16(6):1000-6 - PubMed
  24. Cell Physiol Biochem. 2015;36(4):1597-612 - PubMed
  25. Proteomics. 2013 Aug;13(15):2324-34 - PubMed
  26. Circulation. 2007 Mar 13;115(10 ):1260-8 - PubMed
  27. Am J Cardiol. 1987 Dec 1;60(16):1356-61 - PubMed
  28. Circ Res. 2011 Jan 7;108(1):85-97 - PubMed
  29. Eur J Heart Fail. 2006 Jun;8(4):361-5 - PubMed
  30. J Mol Cell Cardiol. 2006 Aug;41(2):183-214 - PubMed
  31. Mol Ther. 2012 Apr;20(4):727-35 - PubMed
  32. Circulation. 2015 Apr 7;131(14):1247-59 - PubMed
  33. Pharmacol Rev. 2004 Jun;56(2):249-90 - PubMed
  34. Arch Otolaryngol Head Neck Surg. 2004 Dec;130(12):1416-9 - PubMed
  35. J Am Heart Assoc. 2014 Aug 04;3(4):null - PubMed
  36. Am J Physiol. 1989 Oct;257(4 Pt 2):H1254-62 - PubMed
  37. J Immunol. 2004 Sep 15;173(6):3684-92 - PubMed
  38. N Engl J Med. 1999 Sep 2;341(10):709-17 - PubMed
  39. Circulation. 2001 Dec 11;104(24):2996-3007 - PubMed
  40. Expert Opin Ther Targets. 2013 Oct;17(10):1145-66 - PubMed
  41. Circ Res. 2002 Jan 11;90(1):11-3 - PubMed
  42. J Am Coll Cardiol. 2009 Nov 3;54(19):1747-62 - PubMed
  43. DNA Cell Biol. 2015 May;34(5):350-9 - PubMed
  44. Br J Pharmacol. 2012 May;166(1):4-17 - PubMed
  45. Peptides. 1984 Mar-Apr;5(2):325-8 - PubMed
  46. J Biol Chem. 2015 Mar 13;290(11):7003-15 - PubMed
  47. J Am Coll Cardiol. 2014 Dec 23;64(24):2589-600 - PubMed
  48. Tex Heart Inst J. 2009;36(6):510-20 - PubMed
  49. J Am Coll Cardiol. 2008 Jul 29;52(5):347-56 - PubMed
  50. PLoS One. 2013 May 20;8(5):e61449 - PubMed
  51. Basic Res Cardiol. 2000;95 Suppl 1:I98-103 - PubMed
  52. Muscle Nerve. 2009 Jun;39(6):837-44 - PubMed
  53. Expert Rev Cardiovasc Ther. 2013 Jun;11(6):705-17 - PubMed
  54. J Cell Sci. 2001 Jun;114(Pt 11):1971-2 - PubMed
  55. Circulation. 2003 Jul 22;108(3):367-72 - PubMed
  56. J Biol Chem. 2012 May 11;287(20):16670-80 - PubMed
  57. Hippocampus. 2009 Sep;19(9):779-89 - PubMed
  58. Allergy Asthma Clin Immunol. 2011 Nov 29;7:19 - PubMed
  59. J Clin Invest. 2006 Jul;116(7):1828-32 - PubMed

Publication Types

Grant support